PMID: 18196634Jan 16, 2008Paper

Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
V I SkwortsovaO B Kerbikov

Abstract

The multicenter prospective study of cerebrolysin safety and efficacy included 277 patients with ischemic stroke aged 55-85 years, who received therapy within 12 h from the disease development. Cerebrolysin was used in dosage 10 ml daily along with concomitant standard basic treatment during 10 days after stroke onset in 138 patients. A control group comprised 139 patients who received basic treatment only. A quantitative analysis of the dynamics of neurological deficit revealed the accelerated improvement by NIHSS score, modified Rankin score and Barthel index in the cerebrolysin group on days 10 and 28 (p<0,05). The significant improvement of NIHSS score was observed on day 28 (p<0,05) in patients treated with cerebrolysin within the first 3h after stroke onset comparing to those treated within 6-12h. The trial demonstrated cerebrolysin safety and good tolerability in treatment of ischemic stroke in the carotid artery territory as well as its favorable clinical effect.

Related Concepts

Related Feeds

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
N A ShamalovV I Skvortsova
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
A A SkorometsV I Skvortsova
© 2021 Meta ULC. All rights reserved